RIBC CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. RIBC Gen Silencer sind erhältlich als RIBC CRISPR/Cas9 Knockout Plasmide und RIBC Double Nickase Plasmide. RIBC CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
RIBC CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RIBC1 CRISPR/Cas9 KO Plasmid (h) | sc-414799 | h | Gene Knockout | GFP | 0 | ||
RIBC1 HDR Plasmid (h) | sc-414799-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RIBC1 Double Nickase Plasmid (h) | sc-414799-NIC | h | Gene Knockout | Puromycin | 0 | ||
RIBC1 Double Nickase Plasmid (h2) | sc-414799-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RIBC1 CRISPR/Cas9 KO Plasmid (m) | sc-426108 | m | Gene Knockout | GFP | 0 | ||
RIBC1 HDR Plasmid (m) | sc-426108-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RIBC1 Double Nickase Plasmid (m) | sc-426108-NIC | m | Gene Knockout | Puromycin | 0 | ||
RIBC1 Double Nickase Plasmid (m2) | sc-426108-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RIBC2 CRISPR/Cas9 KO Plasmid (h) | sc-411885 | h | Gene Knockout | GFP | 0 | ||
RIBC2 HDR Plasmid (h) | sc-411885-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RIBC2 Double Nickase Plasmid (h) | sc-411885-NIC | h | Gene Knockout | Puromycin | 0 | ||
RIBC2 Double Nickase Plasmid (h2) | sc-411885-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RIBC2 CRISPR/Cas9 KO Plasmid (m) | sc-426724 | m | Gene Knockout | GFP | 0 | ||
RIBC2 HDR Plasmid (m) | sc-426724-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RIBC2 Double Nickase Plasmid (m) | sc-426724-NIC | m | Gene Knockout | Puromycin | 0 | ||
RIBC2 Double Nickase Plasmid (m2) | sc-426724-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RIBC CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RIBC1 CRISPR Activation Plasmid (h) | sc-414799-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 CRISPR Activation Plasmid (h2) | sc-414799-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 Lentiviral Activation Particles (h) | sc-414799-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 Lentiviral Activation Particles (h2) | sc-414799-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 CRISPR Activation Plasmid (m) | sc-426108-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 CRISPR Activation Plasmid (m2) | sc-426108-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 Lentiviral Activation Particles (m) | sc-426108-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC1 Lentiviral Activation Particles (m2) | sc-426108-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 CRISPR Activation Plasmid (h) | sc-411885-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 CRISPR Activation Plasmid (h2) | sc-411885-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 Lentiviral Activation Particles (h) | sc-411885-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 Lentiviral Activation Particles (h2) | sc-411885-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 CRISPR Activation Plasmid (m) | sc-426724-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 CRISPR Activation Plasmid (m2) | sc-426724-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 Lentiviral Activation Particles (m) | sc-426724-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RIBC2 Lentiviral Activation Particles (m2) | sc-426724-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |